Medication info

Senevit Injection

Prescription medicationIntravenous injection
Ingredient · strength
Alpha-Tocopherol›10.2mg / 1 vialCyanocobalamin›0.006mg / 1 vialVitamin A›Strength being verifiedDexpanthenol›16.15mg / 1 vialBiotin›0.069mg / 1 vialCholecalciferol›5.5μg / 1 vialNicotinamide›46mg / 1 vialFolic Acid›0.414mg / 1 vialAscorbic Acid›125mg / 1 vialPyridoxine Hydrochloride›5.5mg / 1 vialRiboflavin Sodium Phosphate Dihydrate›5.67mg / 1 vialCocarboxylase Tetrahydrate›5.8mg / 1 vial
Manufacturer / importer
.
Appearance
A colorless and odorless freeze-dried powder in a brown glass vial
Packaging
10 vials/box
Approval status
Active

MFDS item code 200410157 · Approved 2004.05.10

Summary

Main use
Prevention of vitamin deficiency during intravenous nutritional support
Who receives it
Adults · Children
Adult administration
Adults: Administer 1 vial daily by a separate route. Using a syringe, add 5 mL of water for injection, 5% dextrose injection, or saline injection to the vial and slowly dissolve the powder. After reconstitution, the solution is light orange. After reconstitution, administer by slow intravenous injection or mix with 5% dextrose injection or saline injection and infuse intravenously over at least 10 minutes. This product may be administered during total parenteral nutrition. It may also be mixed with a combination nutrient solution containing carbohydrates, lipids, amino acids, and electrolytes, provided compatibility and stability have been established.
Child administration
Children aged 11 years and older: 1 vial daily

Ingredients

Importer
.

Efficacy & effects

Prevention of vitamin deficiency during intravenous nutritional support

View approved original text

This medicine improves the nutritional status by supplementing necessary vitamins for children over 11 years and adults receiving parenteral nutrition. It helps prevent nutritional deficiencies and maintain bodily functions normally.

How it is given

Adult administration

Adults: Administer 1 vial daily by a separate route. Using a syringe, add 5 mL of water for injection, 5% dextrose injection, or saline injection to the vial and slowly dissolve the powder. After reconstitution, the solution is light orange. After reconstitution, administer by slow intravenous injection or mix with 5% dextrose injection or saline injection and infuse intravenously over at least 10 minutes. This product may be administered during total parenteral nutrition. It may also be mixed with a combination nutrient solution containing carbohydrates, lipids, amino acids, and electrolytes, provided compatibility and stability have been established.

Child administration

Children aged 11 years and older: 1 vial daily

Precautions

This medicine should not be administered more than 5,000 IU of vitamin A per day to women in the first 3 months of pregnancy or those who may become pregnant. This is a precaution to reduce the risk of congenital malformations. Individuals allergic to any ingredient of this medicine or soy and peanut proteins should not use it. Additionally, it should not be used in children under 11 years, patients with vitamin overdose, patients with severe hypercalcemia or hypercalciuria, and patients already taking vitamin A or retinoids. Caution should be exercised when administering this medicine to patients with liver dysfunction or cholestasis, those taking vitamins D or E, and patients with liver or kidney dysfunction. In such cases, regular monitoring of liver function and vitamin levels is essential. This medicine may cause serious allergic reactions such as rash, urticaria, or anaphylaxis, which means that administration should be halted immediately if any abnormal symptoms arise. Excessive intake of vitamins A, D, and E can produce toxicity; therefore, the total vitamin intake must be checked when administering alongside other vitamin supplements or sources of nutrition. The compatibility with other injectable drugs should be confirmed before mixing this medicine, and the solution should be checked for clarity and absence of precipitate before administration. During pregnancy, the dosage of vitamin A from this medicine should be limited to less than 5,000 IU per day; nursing women are advised against use as it may lead to excess vitamin transfer to newborns. Regular clinical tests, such as liver function tests and vitamin blood level tests, should be conducted during the administration of this medicine. Special caution should be taken when interpreting test results as biotin may affect the results of certain laboratory tests. In cases of overdose, administration should be halted immediately, calcium intake should be reduced, and symptoms should be alleviated by promoting diuresis and hydration.

Side effects

chest discomfort, rash, urticaria, erythema, anaphylactic shock, elevated liver enzymes (AST, ALT, γ-GT, ALP), gastrointestinal disturbances, headache, increased intracranial pressure, papilledema, psychiatric disorders, hypersensitivity (convulsions), delayed generalized epidermal desquamation, cortical bone hyperplasia of the ilium, precocious epiphyseal fusion, painful edema, peripheral neuropathy, involuntary movements

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine is sensitive to light; therefore, it should be stored in a container that does not allow light in. Additionally, it is important to keep it in a cool place below 25 degrees Celsius to maintain its efficacy.

Appearance and packaging

Appearance

A colorless and odorless freeze-dried powder in a brown glass vial

Package unit

10 vials/box

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.